Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Results of 5 year phase III randomised trial treating localised prostate cancer

Prof David Dearnaley - Institute of Cancer Research, London, UK

Results of 5 year phase III randomised trial treating localised prostate cancer ( Prof David Dearnaley - Institute of Cancer Research, London, UK )

ECC 2015: Editor's highlights

Prof Gordon McVie - ecancer Managing Editor

ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )

Review of data and expert opinion from IMW 2015: Asian perspective

Prof Joy Ho, Prof Kiyohiko Hatake, Prof Jian Hou, Prof Sung-Soo, Prof Je-Jung...

Review of data and expert opinion from IMW 2015: Asian perspective ( Prof Joy Ho, Prof Kiyohiko Hatake, Prof Jian Hou, Prof Sung-Soo, Prof Je-Jung Lee )

Diagnosis while pregnant should not lead to treatment delay or pregnancy...

Prof Frederic Amant - Katholieke Universiteit Leuven, Leuven, Belgium

Diagnosis while pregnant should not lead to treatment delay or pregnancy termination ( Prof Frederic Amant - Katholieke Universiteit Leuven, Leuven, Belgium )

DDFMISO trial confirms significant negative prognostic value of tumour hypoxia

Prof Michael Baumann - University Hospital Carl Gustav Carus, Dresden, Germany

DDFMISO trial confirms significant negative prognostic value of tumour hypoxia ( Prof Michael Baumann - University Hospital Carl Gustav Carus, Dresden, Germany )

'Survivor passport' for survivors of childhood leukaemia

Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel...

'Survivor passport' for survivors of childhood leukaemia ( Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel, Germany )

Progression of childhood cancers in Europe

Prof Gilles Vassal - University Paris-Sud, Orsay, France

Progression of childhood cancers in Europe ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )

Expanding access to crizotinib using a biomarker-driven approach

Prof Gilles Vassal - University Paris-Sud, Orsay, France

Expanding access to crizotinib using a biomarker-driven approach ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )

Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA

Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )

Latest in lung cancer from ECC 2015

Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer:...

Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )

More from ecancer